Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Enhanced Louisiana Capital is a specialized investment vehicle and Certified Capital Company (CAPCO) operating as a subsidiary of Enhanced Capital Group. The firm focuses on providing venture capital and private credit to small and mid-sized businesses within the state of Louisiana, with a significant emphasis on the healthcare and life sciences sectors. By aligning private sector resources with public policy goals, the company supports regional economic development and innovation in medical technology and healthcare services. Its portfolio has historically included investments in healthcare advocacy, medical facilities, and biotechnology startups. Enhanced Louisiana Capital plays a pivotal role in the Louisiana biotech ecosystem by bridging the funding gap for early-stage and growth-oriented companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Enhanced Louisiana Capital.